taspine has been researched along with Benign Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, Y; Fan, M; Liu, R; Wang, B; Yu, R; Zhang, Y | 1 |
| He, L; Pan, X; Wang, S; Zhang, J; Zhang, Y | 1 |
2 other study(ies) available for taspine and Benign Neoplasms
| Article | Year |
|---|---|
Inhibitory effect of taspine derivative TAD1822-7 on tumor cell growth and angiogenesis via suppression of EphrinB2 and related signaling pathways.
Topics: A549 Cells; Alkaloids; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Down-Regulation; Ephrin-B2; Female; HEK293 Cells; Hep G2 Cells; Humans; Male; Neoplasms; Neovascularization, Pathologic; Rats, Sprague-Dawley; Signal Transduction | 2019 |
Synthesis and cytotoxic evaluation of novel symmetrical taspine derivatives as anticancer agents.
Topics: Alkaloids; Angiogenesis Inhibitors; Antineoplastic Agents; Biphenyl Compounds; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Hydrocarbons, Halogenated; Inhibitory Concentration 50; Molecular Targeted Therapy; Neoplasms; Structure-Activity Relationship | 2011 |